Metsera falls after accepting up to $10 billion sweetened buyout offer from Pfizer

(Reuters) -Shares of Metsera fell over 15% in premarket trading on Monday, after the weight-loss drug developer accepted a ...

These Stocks Are Moving the Most Today: Metsera, Nvidia, Tesla, Rumble, MP Materials, ViaSat, Monday.com, CoreWeave, and More

The Nasdaq Composite gained over 2% Monday, pushed up by investors hopeful that the government shutdown was winding to an end ...
BioSpace

Pfizer’s Winning Bid for Metsera Concludes ‘Real Housewives of Biopharma’

“No need for a reunion show: This seasons Real Housewives of Biopharma comes to a close with Pfizer’s winning bid for Metsera ...
STAT

The $10 billion question: Will Pfizer hit it big with Metsera, or have regrets?

At a price of up to $10 billion, Pfizer has claimed victory in its bidding war against Novo Nordisk to acquire Metsera. It's ...

Pfizer's move for Metsera adds to busy year of healthcare M&A. But the sector's in a rut.

Pfizer's agreement to buy Metsera just adds to the 83 healthcare deals counted by Goldman Sachs that were above $100 million ...
PharmExec

Novo Nordisk Not Planning Increased Proposal Offer After Metsera Enters $10 Billion Amended Merger Agreement with Pfizer

On November 4, 2025, just a day after Pfizer filed its suits against Novo Nordisk and Metsera, Novo Nordisk submitted an ...
STAT

What Pfizer’s Metsera deal means for biotech M&A

That likely only increases the appetite of biotech investors to bet on the next thing. But keep in mind the deal offers some ...

Metsera Shares Fall Premarket as Novo Throws in Towel on Bidding War

Metsera shares fell sharply in premarket trading Monday after the weight-loss drug startup struck a revised deal to be acquired by Pfizer, prompting Danish drugmaker Novo Nordisk to drop out of a ...